載入...
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
Cellular therapies with CD4+ T regulatory cells (Tregs) hold promise of efficacious treatment for the variety of autoimmune and allergic diseases as well as posttransplant complications. Nevertheless, current manufacturing of Tregs as a cellular medicinal product varies between different laboratorie...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Frontiers Media S.A.
2018-01-01
|
叢編: | Frontiers in Immunology |
主題: | |
在線閱讀: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01844/full |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|